Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Freshpet | 10.35% | $5.13M | $2.84B | -62.83% | 68 Neutral | |
| Idexx Laboratories | 10.20% | $5.06M | $58.51B | 69.57% | 75 Outperform | |
| Zoetis | 10.17% | $5.04M | $54.84B | -29.67% | 74 Outperform | |
| Chewy | 10.02% | $4.97M | $13.88B | 3.48% | 54 Neutral | |
| Virbac SA | 7.42% | $3.68M | €2.99B | 10.53% | 75 Outperform | |
| Merck & Company | 4.76% | $2.36M | $250.76B | -0.80% | 76 Outperform | |
| Pets at Home | 4.69% | $2.33M | £960.97M | -7.94% | 74 Outperform | |
| CVS Group plc | 4.67% | $2.31M | £876.61M | 43.49% | 69 Neutral | |
| Nestlé SA | 4.27% | $2.12M | CHF199.66B | 12.93% | 71 Outperform | |
| Pet Valu Holdings Ltd. | 4.24% | $2.10M | C$1.90B | 2.18% | 63 Neutral |